Lipoprotein Receptor-Related Protein-1 Mediates Amyloid-β-Mediated Cell Death of Cerebrovascular Cells

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426 · see citing works

Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier

Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

Neurovascular mechanisms of Alzheimer's neurodegeneration

Zloković, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 921 · see citing works

Metabolic Regulation of Brain Aβ by Neprilysin

Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N., Gerard, C., Hama, E., Lee, H., & Saido, T. (2001) · Science · doi:10.1126/science.1059946 · Cited by 894 · see citing works

LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms

Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828 · see citing works

Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor

Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663 · see citing works

Clearing the brain's amyloid cobwebs

Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541 · see citing works

Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor

Nostrand, W. E. V., Wagner, S. L., Suzuki, M., Choi, B. H., Farrow, J. S., Geddes, J. W., Cotman, C. W., & Cunningham, D. D. (1989) · Nature · doi:10.1038/341546a0 · Cited by 438 · see citing works

Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

Nagele, R. G., D’Andrea, M. R., Lee, H., Venkataraman, V., & Wang, H.-Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02361-8 · Cited by 416 · see citing works

CD36, a Class B Scavenger Receptor, Is Expressed on Microglia in Alzheimer's Disease Brains and Can Mediate Production of Reactive Oxygen Species in Response to β-Amyloid Fibrils

Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398 · see citing works

β‐Amyloid efflux mediated by p‐glycoprotein

Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 379 · see citing works

Modulation of amyloid β-protein clearance and Alzheimer’s disease susceptibility by the LDL receptor–related protein pathway

Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11013 · Cited by 354 · see citing works

Clearing amyloid through the blood-brain barrier

Zlokovic, B. V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02385.x · Cited by 336 · see citing works

Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

van Duinen, S. G., Castaño, E. M., Prelli, F., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5991 · Cited by 309 · see citing works

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease

Kang, D. E., Saitoh, T., Chen, X., Xia, Y., Masliah, E., Hansen, L. A., Thomas, R. G., Thal, L. J., & Katzman, R. (1997) · Neurology · doi:10.1212/wnl.49.1.56 · Cited by 298 · see citing works

Amyloid β42Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1

Le, Y., Gong, W., Tiffany, H. L., Tumanov, A. V., Nedospasov, S. A., Shen, W., Dunlop, N. M., Gao, J., Murphy, P. M., Oppenheim, J. J., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0003.2001 · Cited by 272 · see citing works

Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme

Eckman, E. A., Watson, M., Marlow, L. A., Sambamurti, K., & Eckman, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200642200 · Cited by 263 · see citing works

Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease

Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258 · see citing works

Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains

Wilhelmus, M. M. M., Otte‐Höller, I., Wesseling, P., de Waal, R. M. W., Boelens, W. C., & Verbeek, M. M. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00689.x · Cited by 223 · see citing works

Small heat shock proteins inhibit amyloid-β protein aggregation and cerebrovascular amyloid-β protein toxicity

Wilhelmus, M. M. M., Boelens, W. C., Otte‐Höller, I., Kamps, B., de Waal, R. M. W., & Verbeek, M. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.058 · Cited by 206 · see citing works

Amyloidosis and Alzheimer’s disease

Ghiso, J. A., & Frangione, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00149-7 · Cited by 189 · see citing works

Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

Verbeek, M. M., Otte‐Höller, I., Wesseling, P., Ruiter, D. J., & de Waal, R. M. W. (1994) · PubMed Central · Cited by 187 · see citing works

Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein

Verbeek, M., de Waal, R., Schipper, J., & Nostrand, W. V. V. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031135.x · Cited by 166 · see citing works

Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells

Davis-Salinas, J., Saporito-Irwin, S. M., Cotman, C. W., & Nostrand, W. E. V. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020931.x · Cited by 166 · see citing works

Cerebral Amyloid Angiopathy: Accumulation of Aβ in Interstitial Fluid Drainage Pathways in Alzheimer's Disease

Weller, R. O., Massey, A., Kuo, Y., & Roher, A. E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06356.x · Cited by 151 · see citing works

The Low Density Lipoprotein Receptor Regulates the Level of CentralNervous System Human and Murine Apolipoprotein E but Does Not Modify AmyloidPlaque Pathology in PDAPPMice

Fryer, J. D., DeMattos, R. B., McCormick, L. M., O'Dell, M. A., Spinner, M. L., Bales, K. R., Paul, S. M., Sullivan, P. M., Parsadanian, M., Bu, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502143200 · Cited by 139 · see citing works

β Amyloid peptide (Aβ 42 ) is internalized via the G‐protein‐coupled receptor FPRL1 and forms fibrillar aggregates in macrophages 1

Yazawa, H., Yu, Z., Takeda, K., Le, Y., Gong, W., Ferrans, V. J., Oppenheim, J. J., LI, C. C. H., & Wang, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0251com · Cited by 137 · see citing works

Intracellular and Surface Distribution of Monocyte Tissue Factor

Egorina, E. M., Sovershaev, M. A., Bjørkøy, G., Gruber, F., Olsen, J. O., Parhami-Seren, B., Mann, K. G., & Østerud, B. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000168413.29874.d7 · Cited by 137 · see citing works

LRP in Amyloid‐β Production and Metabolism

Bu, G., Cam, J. A., & Zerbinatti, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.005 · Cited by 133 · see citing works

Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease

Lue, L.-F., Yan, S. D., Stern, D. F., & Walker, D. G. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038210 · Cited by 126 · see citing works

Small heat shock protein HspB8: its distribution in Alzheimer’s disease brains and its inhibition of amyloid-β protein aggregation and cerebrovascular amyloid-β toxicity

Wilhelmus, M. M. M., Boelens, W. C., Otte‐Höller, I., Kamps, B., Küsters, B., Maat–Schieman, M. L. C., de Waal, R. M. W., & Verbeek, M. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0030-z · Cited by 126 · see citing works

Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.

Urmoneit, B., Prikulis, I., Wihl, G. E., D’Urso, D., Frank, R. W., Heeren, J., Beisiegel†, U., & Prior, R. (1997) · PubMed · Cited by 124 · see citing works

The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family

Bu, G. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)09011-8 · Cited by 120 · see citing works

Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses

LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00050-x · Cited by 118 · see citing works

The blood‐brain barrier: Morphology, molecules, and neurothelin

Schlosshauer, B. (1993) · BioEssays · doi:10.1002/bies.950150508 · Cited by 116 · see citing works

Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice

Cao, D., Fukuchi, K.-I., Wan, H., Kim, H., & Li, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.011 · Cited by 106 · see citing works

Pathologic Amyloid β‐Protein Cell Surface Fibril Assembly on Cultured Human Cerebrovascular Smooth Muscle Cells

Nostrand, W. E. V., Melchor, J. P., & Ruffini, L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010216.x · Cited by 102 · see citing works

LRP and senile plaques in Alzheimer’s disease: colocalization with apolipoprotein E and with activated astrocytes

Arélin, K., Kinoshita, A., Whelan, C. M., Irizarry, M. C., Rebeck, G. W., Strickland, D. K., & Hyman, B. T. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00203-6 · Cited by 91 · see citing works

Insulin inhibits amyloid β-induced cell death in cultured human brain pericytes

Rensink, A. A. M., Otte‐Höller, I., de Boer, R., Bosch, R. R., ten Donkelaar, H. J., de Waal, R. M. W., Verbeek, M. M., & Kremer, B. P. H. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00039-3 · Cited by 80 · see citing works

Humanin rescues human cerebrovascular smooth muscle cells from Aβ‐induced toxicity

Jung, S. S., & Nostrand, W. E. V. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01524.x · Cited by 75 · see citing works

Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer ?-amyloid deposition

Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X., & Hirai, S. (1994) · Acta Neuropathologica · doi:10.1007/bf00389492 · Cited by 72 · see citing works

In‐Cell Western assay: a new approach to visualize tissue factor in human monocytes

Egorina, E. M., Sovershaev, M. A., & Østerud, B. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01781.x · Cited by 72 · see citing works

Complement C1-inhibitor expression in Alzheimer's disease

Veerhuis, R., Janssen, I., Hoozemans, J. J. M., Groot, C. J. A. D., Hack, C. E., & Eikelenboom, P. (1998) · Acta Neuropathologica · doi:10.1007/s004010050896 · Cited by 63 · see citing works

Apolipoprotein E Genotype Regulates Amyloid-β Cytotoxicity

Wilhelmus, M. M. M., Otte‐Höller, I., Davis, J., Nostrand, W. E. V., de Waal, R. M. W., & Verbeek, M. M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4213-04.2005 · Cited by 54 · see citing works

Accumulation of the Amyloid-β Precursor Protein in Multivesicular Body-like Organelles

Verbeek, M. M., Otte‐Höller, I., Fransen, J. A. M., & de Waal, R. M. W. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000509 · Cited by 36 · see citing works

Diverse fibrillar peptides directly bind the Alzheimer’s amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation

White, A. R., Maher, F., Brazier, M. W., Jobling, M. F., Thyer, J. M., Stewart, L. R., Thompson, A., Gibson, R., Masters, C. L., Multhaup, G., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04173-2 · Cited by 29 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · see citing works

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243 · see citing works

Central nervous system pericytes in health and disease

Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease

Hamilton, N. B. (2010) · Frontiers in Neuroenergetics · doi:10.3389/fnene.2010.00005 · Cited by 513 · see citing works

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

Roher, A. E., Esh, C. L., Kokjohn, T. A., Castaño, E. M., Vickle, G. D. V., Kalback, W. M., Patton, R., Luehrs, D. C., Daugs, I. D., Kuo, Y., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.10.004 · Cited by 411 · see citing works

Pericytes and Neurovascular Function in the Healthy and Diseased Brain

Brown, L. S., Foster, C. G., Courtney, J.-M., King, N. E., Howells, D. W., & Sutherland, B. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00282 · Cited by 406 · see citing works

Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease

Korte, N., Nortley, R., & Attwell, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02215-w · Cited by 343 · see citing works

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramı́rez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 308 · see citing works

Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies

Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297 · see citing works

Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline

Østergaard, L., Engedal, T. S., Moreton, F. C., Hansen, M. B., Wardlaw, J. M., Dalkara, T., Markus, H. S., & Muir, K. W. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606723 · Cited by 283 · see citing works

Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism

Ma, Q., Zhao, Z., Sagare, A. P., Wu, Y., Wang, M., Owens, N. C., Verghese, P. B., Herz, J., Holtzman, D. M., & Zlokovic, B. V. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0286-0 · Cited by 281 · see citing works

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease

Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281 · see citing works

The Pericyte: A Forgotten Cell Type with Important Implications for A lzheimer's Disease?

Winkler, E. A., Sagare, A. P., & Zloković, B. V. (2014) · Brain Pathology · doi:10.1111/bpa.12152 · Cited by 275 · see citing works

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 271 · see citing works

Multifunctional role of astrocytes as gatekeepers of neuronal energy supply

Stobart, J. L., & Anderson, C. M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00038 · Cited by 266 · see citing works

Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles

Marco, L. Y. D., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 258 · see citing works

Brain microvascular pericytes in health and disease

Dalkara, T., Özdemir, Y., & Yemişçi, M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0847-6 · Cited by 225 · see citing works

Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide

Kováč, A., Erickson, M. A., & Banks, W. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-139 · Cited by 227 · see citing works

LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β

Kanekiyo, T., Liu, C., Shinohara, M., Li, J., & Bu, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-12.2012 · Cited by 221 · see citing works

The capillary dysfunction hypothesis of Alzheimer's disease

Østergaard, L., Aamand, R., Gutiérrez‐Jiménez, E., Ho, Y.-C. L., Blicher, J. U., Madsen, S., Nagenthiraja, K., Dalby, R. B., Drasbek, K. R., Møller, A., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.011 · Cited by 196 · see citing works

Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health

Wheeler, M. J., Dempsey, P. C., Grace, M. S., Ellis, K. A., Gardiner, P. A., GREEN, D. J., & Dunstan, D. W. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.04.001 · Cited by 186 · see citing works

Vascular contributions to Alzheimer's disease

Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 179 · see citing works

Astrocytic Aβ1‐42 uptake is determined by Aβ‐aggregation state and the presence of amyloid‐associated proteins

Nielsen, H., Mulder, S., Beliën, J., Musters, R., Eikelenboom, P., & Veerhuis, R. (2010) · Glia · doi:10.1002/glia.21004 · Cited by 140 · see citing works

Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood–brain barrier

Erickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-150 · Cited by 145 · see citing works

Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo

Kafa, H., Wang, J. T.-W., Rubio, N., Klippstein, R., Costa, P. M., Hassan, H. A. F. M., Sosabowski, J. K., Bansal, S. S., Preston, J. E., Abbott, N. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.031 · Cited by 145 · see citing works

The role of astrocytes in amyloid β-protein toxicity and clearance

Thal, D. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.021 · Cited by 141 · see citing works

β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease

Li, J., Li, M., Ge, Y., Chen, J., Ma, J., Wang, C., Sun, M., Wang, L., Yao, S., & Yao, C. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00807-5 · Cited by 145 · see citing works

The Neurovascular Unit Dysfunction in Alzheimer’s Disease

Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 140 · see citing works

Age-Dependent Neurovascular Dysfunction and Damage in a Mouse Model of Cerebral Amyloid Angiopathy

Park, L., Koizumi, K., Jamal, S. E., Zhou, P., Previti, M. L., Nostrand, W. E. V., Carlson, G. A., & Iadecola, C. (2014) · Stroke · doi:10.1161/strokeaha.114.005179 · Cited by 129 · see citing works

Cerebral microvascular pericytes and neurogliovascular signaling in health and disease

Dalkara, T., & Alarcón-Martínez, L. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.047 · Cited by 126 · see citing works

Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance

Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127 · see citing works

The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders

ElAli, A., Thériault, P., & Rivest, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046453 · Cited by 120 · see citing works

Phagocytic Clearance in Neurodegeneration

Sokolowski, J. D., & Mandell, J. W. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.051 · Cited by 117 · see citing works

Pericyte Structural Remodeling in Cerebrovascular Health and Homeostasis

Berthiaume, A., Hartmann, D. A., Majesky, M. W., Bhat, N. R., & Shih, A. Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00210 · Cited by 112 · see citing works

Use of LDL receptor—targeting peptide vectors for in vitro and in vivo cargo transport across the blood‐brain barrier

Molino, Y., David, M., Varini, K., Jabès, F., Gaudin, N., Fortoul, A., Bakloul, K., Masse, M., Bernard, A., Drobecq, L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600827r · Cited by 112 · see citing works

The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease

ElAli, A., & Rivest, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00045 · Cited by 109 · see citing works

Capillary Dysfunction: Its Detection and Causative Role in Dementias and Stroke

Østergaard, L., Jespersen, S. N., Engedahl, T., Jiménez, E. G., Ashkanian, M., Hansen, M. B., Eskildsen, S. F., & Mouridsen, K. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0557-x · Cited by 106 · see citing works

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1

Bertrand, Y., Currie, J.-C., Poirier, J., Demeule, M., Abulrob, A., Fatehi, D., Stanimirovic, D. B., Sartelet, H., Castaigne, J., & Béliveau, R. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.427 · Cited by 100 · see citing works

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: Use of an in vitro model

Gosselet, F., Candela, P., Sevin, E., Bérézowski, V., Cecchelli, R., & Fénart, L. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.036 · Cited by 97 · see citing works

The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.

Mulder, S., Veerhuis, R., Blankenstein, M., & Nielsen, H. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.001 · Cited by 95 · see citing works

Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease

Csiszar, A., Tarantini, S., Fülöp, G. A., Kiss, T., Valcarcel-Ares, M. N., Galvan, V., Ungvari, Z., & Yabluchanskiy, A. (2017) · GeroScience · doi:10.1007/s11357-017-9991-9 · Cited by 93 · see citing works

Transglutaminases and Transglutaminase‐Catalyzed Cross‐Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

Wilhelmus, M. M. M., Grunberg, S. C. S., Bol, J. G. J. M., van Dam, A., Hoozemans, J. J. M., Rozemüller, A. J. M., & Drukarch, B. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00197.x · Cited by 90 · see citing works

Aβ Internalization by Neurons and Glia

Mohamed, A., & Chaves, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/127984 · Cited by 91 · see citing works

Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma

Li, Y., Zheng, X., Gong, M., & Zhang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12708 · Cited by 90 · see citing works

Apolipoproteins E and J interfere with amyloid‐beta uptake by primary human astrocytes and microglia in vitro

Mulder, S. D., Nielsen, H. M., Blankenstein, M. A., Eikelenboom, P., & Veerhuis, R. (2014) · Glia · doi:10.1002/glia.22619 · Cited by 84 · see citing works

The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease

Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85 · see citing works

Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier

Biemans, E. A. L. M., Jäkel, L., de Waal, R. M. W., Kuiperij, H. B., & Verbeek, M. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23964 · Cited by 85 · see citing works

Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer’s disease

Bourassa, P., Tremblay, C., Schneider, J. A., Bennett, D. A., & Calon, F. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01967-4 · Cited by 79 · see citing works

The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease

Wan, W., Chen, H., & Li, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.825258 · Cited by 81 · see citing works

Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress

Uekawa, K., Hattori, Y., Ahn, S. J., Seo, J., Casey, N., Anfray, A., Zhou, P., Luo, W., Anrather, J., Park, L., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00660-1 · Cited by 80 · see citing works

Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection

Erdener, Ş. E., & Dalkara, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00889 · Cited by 76 · see citing works

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 79 · see citing works

Amyloid‐beta 1‐40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro

Schultz, N., Brännström, K., Byman, E., Moussaud, S., Nielsen, H. M., Bank, T. N. B., Olofsson, A., & Wennström, M. (2018) · Aging Cell · doi:10.1111/acel.12728 · Cited by 73 · see citing works

Transport characteristics of a novel peptide platform for CNS therapeutics

Bertrand, Y., Currie, J.-C., Demeule, M., Régina, A., Ché, C., Abulrob, A., Fatehi, D., Sartelet, H., Gabathuler, R., Castaigne, J., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00930.x · Cited by 74 · see citing works

In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes

Candela, P., Saint‐Pol, J., Kuntz, M., Boucau, M., Lamartinière, Y., Gosselet, F., & Fénart, L. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.047 · Cited by 71 · see citing works

Brain Pericytes ABCA1 Expression Mediates Cholesterol Efflux but not Cellular Amyloid-β Peptide Accumulation

Saint-Pol, J., Vandenhaute, E., Boucau, M., Candela, P., Dehouck, L., Cecchelli, R., Dehouck, M., Fenart, L., & Gosselet, F. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112090 · Cited by 63 · see citing works

High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity

Qosa, H., Mohamed, L. A., Rihani, S. B. A., Batarseh, Y. S., Duong, Q.-V., Keller, J. N., & Kaddoumi, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151179 · Cited by 62 · see citing works

Beyond barrier functions: Roles of pericytes in homeostasis and regulation of neuroinflammation

Bhattacharya, A., Kaushik, D. K., Lozinski, B. M., & Yong, V. W. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24715 · Cited by 60 · see citing works

Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer

Petra, E. S. (2012) · Frontiers in bioscience · doi:10.2741/4035 · Cited by 62 · see citing works

Apolipoprotein E protects cultured pericytes and astrocytes from D-Aβ1–40-mediated cell death

Bruinsma, I. B., Wilhelmus, M. M. M., Kox, M., Veerhuis, R., de Waal, R. M. W., & Verbeek, M. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.12.039 · Cited by 58 · see citing works

Structure of the Blood Brain Barrier and its Role in the Transporters for the Movement of Substrates across the Barriers

Ankul Singh, S., & Vellapandian, C. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230608110349 · Cited by 57 · see citing works

Impact of intestinal disorders on central and peripheral nervous system diseases

El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 54 · see citing works

Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4

Bilousova, T. V., Melnik, M., Miyoshi, E., Gonzalez, B. L., Poon, W. W., Vinters, H. V., Miller, C. A., Corrada, M. M., Kawas, C. H., Hatami, A., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.04.010 · Cited by 54 · see citing works

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?

Kacířová, M., Zmeškalová, A., Kořínková, L., Železná, B., Kuneš, J., & Maletı́nská, L. (2020) · Clinical Science · doi:10.1042/cs20191313 · Cited by 53 · see citing works

Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis

Wilhelmus, M. M. M., Bol, J. G. J. M., van Haastert, E. S., Rozemüller, A. J. M., Bu, G., Drukarch, B., & Hoozemans, J. J. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.021 · Cited by 52 · see citing works

Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit

Veszelka, S., Tóth, A. E., Walter, F. R., Datki, Z., Mózes, E., Fülöp, L., Bozsó, Z., Hellinger, É., Vastag, M., Orsolits, B., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-120163 · Cited by 51 · see citing works

Pericyte Plasticity in the Brain

Santos, G. S. P., Magno, L. A. V., Romano‐Silva, M. A., Mintz, A., & Birbrair, A. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0296-5 · Cited by 49 · see citing works

JAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages

Hashimoto, R., Kakigi, R., Miyamoto, Y., Nakamura, K., Itoh, S., Daida, H., Okada, T., & Katoh, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172940 · Cited by 52 · see citing works

Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor Processing

Bachmeier, C. J., Shackleton, B., Ojo, J. O., Paris, D., MULLAN, M. J., & Crawford, F. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8318-6 · Cited by 50 · see citing works

Amyloid-β Interacts with Blood-Brain Barrier Function in Dementia: A Systematic Review

Burgmans, S., van de Haar, H. J., Verhey, F. R. J., & Backes, W. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122155 · Cited by 47 · see citing works

Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood–cerebrospinal fluid barrier in human brain

Matsumoto, K., Chiba, Y., Fujihara, R., Kubo, H., Sakamoto, H., & Ueno, M. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1366-7 · Cited by 46 · see citing works

Low-density Lipoprotein Receptor-related Protein 1 (LRP1)-dependent Cell Signaling Promotes Axonal Regeneration

Yoon, C., van Niekerk, E. A., Henry, K. W., Ishikawa, T., Orita, S., Tuszynski, M. H., & Campana, W. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478552 · Cited by 46 · see citing works

Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

Martiskainen, H., Haapasalo, A., Kurkinen, K. M. A., Pihlajamäki, J., Soininen, H. S., & Hiltunen, M. O. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.789862 · Cited by 45 · see citing works

Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease

Alcendor, D. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051490 · Cited by 47 · see citing works

Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease

Fiala, M., & Veerhuis, R. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.003 · Cited by 45 · see citing works

Involvement of Matrix Metalloproteinase-9 in Amyloid-β 1–42–Induced Shedding of the Pericyte Proteoglycan NG2

Schultz, N., Nielsen, H. M., Minthon, L., & Wennström, M. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000084 · Cited by 43 · see citing works

The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD

Hunter, S., Arendt, T., & Brayne, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8445-3 · Cited by 46 · see citing works

Assessment of microvascular rarefaction in human brain disorders using physiological magnetic resonance imaging

van Dinther, M., Voorter, P., Jansen, J. F. A., Jones, E. A. V., van Oostenbrugge, R. J., Staals, J., & Backes, W. H. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221076557 · Cited by 39 · see citing works

Modeling cerebrovascular pathophysiology in amyloid-β metabolism using neural-crest-derived smooth muscle cells

Cheung, C., Goh, Y. T., Zhang, J., Wu, C., & Guccione, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.065 · Cited by 35 · see citing works

Influence of LRP-1 and Apolipoprotein E on Amyloid-β Uptake and Toxicity to Cerebrovascular Smooth Muscle Cells

Ruzali, W. A. W., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121336 · Cited by 34 · see citing works

The Imbalance of Vascular Molecules in Alzheimer's Disease

Bell, R. D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121060 · Cited by 35 · see citing works

Oxysterols and the NeuroVascular Unit (NVU): A far true love with bright and dark sides

Saint‐Pol, J., & Gosselet, F. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.017 · Cited by 33 · see citing works

The vascular contribution to cognitive decline in ageing and dementia

Anderle, S., Dixon, M., Quintela‐López, T., Sideris-Lampretsas, G., & Attwell, D. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00950-1 · Cited by 38 · see citing works

Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease

Li, P., Wu, Y., Hamlett, E. D., Goodwin, A. J., Halushka, P. V., Carroll, S. L., Liu, M., & Fan, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.023 · Cited by 33 · see citing works

Distribution of neprilysin and deposit patterns of Aβ subtypes in the brains of aged squirrel monkeys (<i>Saimiri sciureus</i>)

Chambers, J. K., Kuribayashi, H., Ikeda, S.-I., & Une, Y. (2010) · Amyloid · doi:10.3109/13506129.2010.483119 · Cited by 32 · see citing works

Tissue Transglutaminase in Alzheimer's Disease: Involvement in Pathogenesis and its Potential as a Therapeutic Target

Wilhelmus, M. M. M., de Jager, M., Bakker, E. N. T. P., & Drukarch, B. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132492 · Cited by 32 · see citing works

Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier

Griffin, J. M., Kho, D. T., Graham, E. S., Nicholson, L. F. B., & O’Carroll, S. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157483 · Cited by 32 · see citing works

From the low-density lipoprotein receptor–related protein 1 to neuropathic pain: a potentially novel target

García-Fernández, P., Üçeyler, N., & Sommer, C. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000898 · Cited by 31 · see citing works

Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer’s Disease

Yang, P., Li, Y., Qian, K., Zhou, L., Cheng, Y., Wu, J., Xu, M., Wang, T., Yang, X., Mu, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c00480 · Cited by 30 · see citing works

Pericytes in Alzheimer’s Disease: Novel Clues to Cerebral Amyloid Angiopathy Pathogenesis

Salmina, A. B., Komleva, Y. K., Lopatina, O. L., & Birbrair, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16908-4_7 · Cited by 28 · see citing works

Immunohistochemical study of semicarbazide‐sensitive amine oxidase/vascular adhesion protein‐1 in the hippocampal vasculature: Pathological synergy of Alzheimer's disease and diabetes mellitus

Valente, T., Gella, A., Solé, M., Durany, N., & Unzeta, M. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23092 · Cited by 26 · see citing works

LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: Relationship to cerebral amyloid angiopathy and APOE status

Ruzali, W. A. W., Kehoe, P. G., & Love, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.065 · Cited by 23 · see citing works

Haptoglobin Modulates Beta-Amyloid Uptake by U-87 MG Astrocyte Cell Line

Maresca, B., Spagnuolo, M. S., & Cigliano, L. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0465-6 · Cited by 20 · see citing works

Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons

Hu, H., Wan, S., Hu, Y., Wang, Q., Li, H., & Zhang, N. (2025) · Annals of Medicine · doi:10.1080/07853890.2024.2445194 · Cited by 19 · see citing works

The blood clotting F actor XIIIa forms unique complexes with amyloid‐beta ( A β) and colocalizes with deposited A β in cerebral amyloid angiopathy

de Jager, M., Boot, M. V., Bol, J. G. J. M., Brevé, J. J. P., Jongenelen, C. A. M., Drukarch, B., & Wilhelmus, M. M. M. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12244 · Cited by 18 · see citing works

Tissue transglutaminase‐catalysed cross‐linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid‐beta‐induced toxicity

de Jager, M., Drukarch, B., Hofstee, M. I., Brevé, J. J. P., Jongenelen, C. A. M., Bol, J. G. J. M., & Wilhelmus, M. M. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13203 · Cited by 15 · see citing works

Amyloid β induces cellular relocalization and production of agrin and glypican-1

Timmer, N., van Horssen, J., Otte‐Höller, I., Wilhelmus, M. M. M., David, G., van Beers, J. J. B. C., de Waal, R. M. W., & Verbeek, M. M. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.063 · Cited by 17 · see citing works

LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β

Kanekiyo, T., Liu, C., Shinohara, M., Li, J., & Bu, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-12.2012 · Cited by 221 · see citing works

The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells

Yamada, K., Hashimoto, T., Yabuki, C., Nagae, Y., Tachikawa, M., Strickland, D. K., Liu, Q., Bu, G., Basak, J. M., Holtzman, D. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801487200 · Cited by 119 · see citing works

α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related Protein

Narita, M., Holtzman, D. M., Schwartz, A. L., & Bu, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051904.x · Cited by 259 · see citing works

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease

Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281 · see citing works

Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes

Basak, J. M., Verghese, P. B., Yoon, H., Kim, J., & Holtzman, D. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288746 · Cited by 192 · see citing works